Meghan McCarthy

Meghan McCarthy

Auto-generated profile, based on publicly available information

Meghan McCarthy

Warren Alpert Medical School of Brown University Providence Rhode Island USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 December 2020 in International Journal Of Clinical Practice
Verified
Journal Article
Open access
PDF file
YSYiyun Shi
Yiyun Shi
APAakriti Pandita
Aakriti Pandita
AHAnna Hardesty
Anna Hardesty
MMMeghan McCarthy
Meghan McCarthy
JAJad Aridi
Jad Aridi
DFDimitrios Farmakiotis
Dimitrios Farmakiotis
Objective We aimed to externally validate the predictive performance of two recently developed COVID‐19‐specific prognostic tools, the COVID‐GRAM and CALL scores, and prior prognostic scores for community‐acquired pneumonia (CURB‐65), viral pneumonia (MuBLSTA) and H1N1 influenza pneumonia (Influenza risk score) in a contemporary US cohort. Methods We included 257 hospitalized patients with laboratory‐confirmed COVID‐19 pneumonia from three teaching hospitals in Rhode Island. We extracted data from within the first 24 hours of admission. Variables were excluded if values were missing in >20% of cases, otherwise missing values were imputed. 115 patients with complete data after imputation were used for primary analysis. Sensitivity analysis was done after exclusion of one variable (LDH) in the complete dataset (n=257). Primary and secondary outcomes were in‐hospital mortality and critical illness (mechanical ventilation or death), respectively. Results Only the areas under the receiver‐operating characteristic curves (RO‐AUC) of COVID‐GRAM (0.775, 95%CI 0.525‐0.915) for in‐hospital death, and CURB65 for in‐hospital death (RO‐AUC 0.842, 95%CI 0.674‐0.932) or critical illness (RO‐AUC=0.766, 95%CI 0.584‐0.884) were significantly better than random. Sensitivity analysis yielded similar trends. Calibration plots showed better agreement between estimated and observed probability of in‐hospital death for CURB65, compared to COVID‐GRAM. The negative predictive value (NPV) of CURB65≥2 was 97.2% for in‐hospital death and 88.1% for critical illness. Conclusions The COVID‐GRAM score demonstrated acceptable predictive performance for in‐hospital death. The CURB65 score had better prognostic utility for in‐hospital death and critical illness. The high NPV of CURB65 values ≥2, may be useful in triaging and allocation of resources.

15 December 2022 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
CMCamille Mathey-Andrews
Camille Mathey-Andrews
MMMeghan McCarthy
Meghan McCarthy
APAlexandra L. Potter
Alexandra L. Potter
JBJorind Beqari
Jorind Beqari
SWSean C. Wightman
Sean C. Wightman
CYChi-Fu J. Yang
Chi-Fu J. Yang

25 February 2025 in Public Health Challenges
Verified
Journal Article
Open access
MMMeghan L. McCarthy
Meghan L. McCarthy
JBJonah Bradenday
Jonah Bradenday
ECElizabeth Chen
Elizabeth Chen
MZMark R. Zonfrillo
Mark R. Zonfrillo
Indra SarkarIndra Sarkar
Indra Sarkar
Background and Objectives: Among the multitude of health effects on children associated with the COVID‐19 pandemic, there have been significant interruptions in the provision of routine pediatric primary care, including blood lead level (BLL) screening. We aimed to investigate trends in BLL screening before and during the pandemic era using patient‐level electronic health record data extracted from CurrentCare, Rhode Island's statewide health information exchange (HIE).Methods: De‐identified data were analyzed from CurrentCare for the study period January 2018 to December 2021. We utilized ATLAS, a web‐based analytics platform from the Observational Health Data Sciences and Informatics (OHDSI) community, to extract and stratify BLL by variables of interest from the CurrentCare data, standardized to OHDSI's Observational Medical Outcomes Partnership common data model.Results: A decrease in BLL screening occurred in the spring of 2020, aligning with initial periods of shelter‐in‐place in response to the novel coronavirus outbreak; there was a 48% decrease comparing quarter 2 (April to June) of 2019 and 2020. BLL screening rebounded in the summer of 2020, however, it remained 16% lower overall in 2020 than in 2019. In 2021, BLL screening fell again to 23% lower than in 2019. Although overall numbers of BLL screenings were reduced, the proportion of abnormal BLLs was higher, particularly in the range of 3.5–5.0 µg/dL.Conclusions: Leveraging statewide HIE data, we found that significant deficiencies in BLL screening remain unresolved since the beginning of the COVID‐19 pandemic. The disruption of children's lives by the COVID‐19 pandemic appears to have greatly affected lead screening and exposure in Rhode Island.